These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2407335)

  • 1. A useful monoclonal antibody (BL2-10D1) to identify tumor cells in urine cytology.
    Longin A; Fontaniere B; Berger-Dutrieux N; Devonec M; Laurent JC
    Cancer; 1990 Mar; 65(6):1412-7. PubMed ID: 2407335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of monoclonal antibody BL2-10D1 as a marker for the detection of the urothelial origin of tumors.
    Longin A; Berger-Dutrieux N; Fontaniere B; Cochran AJ; Devonec M; Dolbeau D; Guillaud M; Laurent JC
    Cancer; 1993 Nov; 72(9):2651-5. PubMed ID: 7691394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of standard cytology and immunocytology with BL2-10D1 monoclonal antibody for monitoring-treated bladder cancer patients.
    Chicheportiche C; Gazarossian E; Longin A; Lebreuil G; Hermanowicz M; Richaud C; Beley S; Kaphan S; Fontanière B; Cotte G
    Eur Urol; 1993; 23(3):405-8. PubMed ID: 7685288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody (BL2-10D1) reacting with a bladder-cancer-associated antigen.
    Longin A; Hijazi A; Berger-Dutrieux N; Escourrou G; Bouvier R; Richer G; Mironneau I; Fontanière B; Devonec M; Laurent JC
    Int J Cancer; 1989 Feb; 43(2):183-9. PubMed ID: 2645218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine.
    Golijanin D; Sherman Y; Shapiro A; Pode D
    Urology; 1995 Aug; 46(2):173-7. PubMed ID: 7624989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine cytology in bladder tumors.
    Zein TA; Milad MF
    Int Surg; 1991; 76(1):52-4. PubMed ID: 2045253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary nuclear matrix protein 22 (NMP22): a diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder.
    Hughes JH; Katz RL; Rodriguez-Villanueva J; Kidd L; Dinney C; Grossman HB; Fritsche HA
    Diagn Cytopathol; 1999 May; 20(5):285-90. PubMed ID: 10319229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms.
    Murphy WM; Soloway MS; Jukkola AF; Crabtree WN; Ford KS
    Cancer; 1984 Apr; 53(7):1555-65. PubMed ID: 6697294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder wash cytology and flow cytometry for the diagnosis of transitional cell carcinoma of the urinary bladder.
    Romero J; Alos L; Mallofre C; Sole M; Gutierrez R; Alcover J; Carretero P
    Eur Urol; 1992; 21 Suppl 1():13-5. PubMed ID: 1425832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
    Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
    J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
    Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voided urinary cytology in bladder cancer: is it time to review the indications?
    Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
    Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine.
    Renshaw AA; Nappi D; Weinberg DS
    Acta Cytol; 1996; 40(4):676-82. PubMed ID: 8693885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry based on heterogeneity index score compared with urine cytology to evaluate their diagnostic efficacy in bladder tumor.
    Jitsukawa S; Tachibana M; Nakazono M; Tazaki H; Addonizio JC
    Urology; 1987 Feb; 29(2):218-22. PubMed ID: 3811103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing.
    Chopin DK; deKernion JB; Rosenthal DL; Fahey JL
    J Urol; 1985 Aug; 134(2):260-5. PubMed ID: 3894692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.